PTG-100, an Oral α4β7 Antagonist Peptide: Preclinical Development and Phase 1 and 2a Studies in Ulcerative ColitisWilliam J. Sandborn, Suneel Gupta, Nishit B. Modi et al.|Gastroenterology|2021Cited by 37